Algert Global LLC Decreases Stake in Sotera Health Company $SHC

Key Points

• Algert Global reduced its Sotera Health stake by 15.6% in the second quarter, selling 66,610 shares and retaining 361,280 shares worth approximately $6.4 million. Institutional investors collectively own 91.03% of SHC.
• Sotera Health reported a quarterly earnings and revenue beat, with EPS of $0.26 versus $0.24 expected and revenue of $321.38 million, up 9.2% year over year.
• Analyst sentiment remains favorable: eight analysts rate the stock Buy and three rate it Hold, producing a “Moderate Buy” consensus and an average price target of $21.50. However, insiders sold about 1.29 million shares worth nearly $24 million over the past three months.

Algert Global LLC lowered its position in Sotera Health Company (NASDAQ:SHC - Free Report) by 15.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 361,280 shares of the company's stock after selling 66,610 shares during the period. Algert Global LLC owned approximately 0.13% of Sotera Health worth $6,413,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. IFP Advisors Inc grew its position in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company's stock valued at $26,000 after purchasing an additional 1,371 shares during the period. Rothschild Investment LLC purchased a new stake in Sotera Health in the 4th quarter valued at about $27,000. Root Financial Partners LLC increased its stake in shares of Sotera Health by 217.5% during the 1st quarter. Root Financial Partners LLC now owns 2,124 shares of the company's stock valued at $30,000 after acquiring an additional 1,455 shares during the last quarter. Meeder Asset Management Inc. purchased a new position in shares of Sotera Health during the 2nd quarter worth about $37,000. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company's stock worth $37,000 after acquiring an additional 2,935 shares during the period. Hedge funds and other institutional investors own 91.03% of the company's stock.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, Chairman Michael B. Jr. Petras sold 850,000 shares of the company's stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman directly owned 3,969,393 shares of the company's stock, valued at $73,433,770.50. This represents a 17.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Michael P. Rutz sold 150,000 shares of Sotera Health stock in a transaction on Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares of the company's stock, valued at approximately $6,297,816.36. The trade was a 30.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 1,294,515 shares of company stock worth $23,999,528. Company insiders own 15.36% of the company's stock.

Sotera Health Stock Performance

Shares of SHC stock opened at $19.54 on Thursday. The firm has a market capitalization of $5.58 billion, a price-to-earnings ratio of 34.28 and a beta of 1.77. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55. Sotera Health Company has a 12-month low of $13.09 and a 12-month high of $19.85. The business has a 50 day simple moving average of $17.98 and a 200 day simple moving average of $16.38.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The firm had revenue of $321.38 million during the quarter, compared to analyst estimates of $309.70 million. During the same period last year, the company posted $0.20 EPS. The firm's quarterly revenue was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, equities research analysts anticipate that Sotera Health Company will post 0.86 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently weighed in on SHC. Piper Sandler reaffirmed an "overweight" rating and issued a $25.00 target price (up from $22.00) on shares of Sotera Health in a research report on Friday, August 7th. JPMorgan Chase & Co. raised their price objective on Sotera Health from $16.00 to $18.00 and gave the stock a "neutral" rating in a report on Friday, August 7th. Weiss Ratings raised Sotera Health from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, August 11th. The Goldman Sachs Group started coverage on shares of Sotera Health in a report on Friday, June 5th. They issued a "buy" rating and a $20.00 price target on the stock. Finally, Barclays raised their target price on shares of Sotera Health from $19.00 to $22.00 and gave the company an "overweight" rating in a research note on Friday, August 7th. Eight analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $21.50.

Sotera Health Company Profile

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source